Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells. On Tuesday, researchers said a single dose of those revved-up cells ...

Rutgers University researchers find that certain aging immune T cells can blunt cell expansion and may help explain why many ...

In this retrospective analysis, researchers used real-world data to investigate sex-associated differences in CAR T-cell therapy-related toxicity.

Scientists want to know what causes B cells — which direct T cells to attack cancer — to malfunction and how they can be ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the presentation of preclinical data demonstrating that a ...

CAR T-cell therapy is a treatment that uses a patient’s own T cells, genetically reprograms them in a lab to recognize myeloma cells, and then infuses them back into the body to attack the cancer.

Soficabtagene geleucel (WU-CART-007) received FDA Breakthrough Therapy Designation for treating relapsed or refractory T-cell leukemia and lymphoma. The CRISPR-engineered treatment achieved a 91% ...

A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T cells.

Please provide your email address to receive an email when new articles are posted on . Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led ...